Tanvex BioPharma Inc (6541) — Strategic Asset Allocation Index
Tanvex BioPharma Inc (6541) has a Strategic Asset Allocation Index of 113.5% as of June 2023. Strategic assets (PP&E of NT$2.03 Billion plus long-term investments of NT$-) total NT$2.03 Billion, measured against net assets of NT$1.79 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Tanvex BioPharma Inc net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Tanvex BioPharma Inc Strategic Asset Allocation Index (2016–2022)
This chart shows how Tanvex BioPharma Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 113.5%, representing strategic assets of NT$2.03 Billion against net assets of NT$1.79 Billion TWD. For live market cap and overall valuation, see market value of Tanvex BioPharma Inc.
Annual Strategic Asset Allocation Index for Tanvex BioPharma Inc (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Tanvex BioPharma Inc from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 6541 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 154.6% | NT$2.15 Billion | NT$2.15 Billion | NT$- | NT$1.39 Billion | ▲ +78.9 pp |
| 2021 | 75.6% | NT$2.11 Billion | NT$2.11 Billion | NT$- | NT$2.79 Billion | ▲ +2.9 pp |
| 2020 | 72.7% | NT$1.91 Billion | NT$1.91 Billion | NT$- | NT$2.62 Billion | ▲ +42.3 pp |
| 2019 | 30.5% | NT$922.96 Million | NT$922.96 Million | NT$- | NT$3.03 Billion | ▲ +13.0 pp |
| 2018 | 17.5% | NT$735.55 Million | NT$735.55 Million | NT$- | NT$4.21 Billion | ▼ -2.5 pp |
| 2017 | 19.9% | NT$747.17 Million | NT$747.17 Million | NT$- | NT$3.75 Billion | ▼ -3.4 pp |
| 2016 | 23.3% | NT$832.55 Million | NT$832.55 Million | NT$- | NT$3.57 Billion | — |